Stay updated on VX-880 in Type 1 Diabetes: Safety Clinical Trial
Sign up to get notified when there's something new on the VX-880 in Type 1 Diabetes: Safety Clinical Trial page.

Latest updates to the VX-880 in Type 1 Diabetes: Safety Clinical Trial page
- CheckyesterdayChange DetectedA new release revision v3.6.5 was added and the previous v3.6.4 was removed, reflecting the page's updated software version in its release notes.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now displays a revision tag showing v3.6.4, replacing the previous v3.6.3. This indicates the page has been updated to version 3.6.4, reflecting an admin-level update rather than a change to trial details.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedThe study page now shows the status as Completed as of 2026-06-30. It also updates the Vertex data sharing information to the new URL and revision (v3.6.3), replacing the previous data-sharing link and version.SummaryDifference0.3%

- Check44 days agoChange DetectedThe page footer now shows Revision: v3.6.2, replacing the previous v3.6.0. This indicates a minor update to the page's version and metadata.SummaryDifference0.0%

- Check58 days agoChange DetectedNew navigation items were added: Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment, and a Revision: v3.6.0. The old navigation label Intervention / Treatment and the Revision: v3.5.5 tag were removed.SummaryDifference0.4%

- Check65 days agoChange DetectedNew page revision v3.5.5 has been published, replacing the previous v3.5.4. This update appears to be a metadata/version change rather than a modification to the study details.SummaryDifference0.0%

Stay in the know with updates to VX-880 in Type 1 Diabetes: Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VX-880 in Type 1 Diabetes: Safety Clinical Trial page.